Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.

Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2024 Mar; 30(3):255-267.

View in: PubMed

subject areas

Amides
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Humans
Morbidity
Neoplasm Recurrence, Local
Prospective Studies
Recurrence
Sulfones
Transplantation, Homologous
Unrelated Donors

authors with profiles

Lucy Godley